Gelison, Janelle L.

HRN: 16-82-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2022
CEFUROXIME 1.5GM (VIAL)
09/06/2022
09/13/2022
IV
290mg
Q8hours
UTI
Waiting Final Action 
09/06/2022
CEFTRIAXONE 1G (VIAL)
09/06/2022
09/12/2022
IV DRIP
1 Gram
Q24
Consolidative Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: